Effects of the potential antidepressant AHR-1118 on amine uptake and on plasma 3-methoxy-4-hydroxyphenylglycol in manic-depressive illness [proceedings].
D000818:Animals; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001679:Biogenic Amines / Q000378:metabolism*; D001714:Bipolar Disorder / Q000188:drug therapy / Q000378:metabolism*; D006018:Glycols / Q000378:metabolism*; D006801:Humans; D008734:Methoxyhydroxyphenylglycol / Q000378:metabolism*; D011759:Pyrrolidines / Q000009:adverse effects*; D051381:Rats; D013997:Time Factors
D000928:Antidepressive Agents; D001679:Biogenic Amines; D006018:Glycols; D011759:Pyrrolidines; D008734:Methoxyhydroxyphenylglycol